Bronchodilator efficacy of metaproterenol sulfate aerosol therapy delivered either by canister
or jet nebulizer was compared in 25 patients, 13 with severe asthma and 12 with COPD …

In 19 asthmatic patients, three inhalations of metaproterenol (0.65 mg per puff) followed by
placebo at 10 and 20 min were compared with one inhalation of the drug every 10 min for …

The bronchodilator response to metaproterenol delivered by metered-dose inhaler (MDI)
with a spacer device (Aerochamber [A]) and by jet nebulizer was studied in 44 asthmatic …

One hundred patients with acute asthma and peak expiratory flow rates (PEFR)< 150 L/min
were randomized and treated in a double-blind treatment protocol with either …

The aerosolized administration of betaadrenergic bronchodilators is of documented efficacy
in the treatment of bronchospastic lung disease (1-3). Aerosolized bronchodilators …

Conflicting reports have appeared concerning the role of anticholinergic agents in the
treatment of acute asthma. This study was designed to determine whether atropine sulfate …

The effects of aerosolized metaproterenol (1.30 mg) and isoetharine (1.02 mg) on
nonspecific airway responsiveness to inhaled methacholine were quantitated and compared …

This study compared two beta-adrenergic agents in the treatment of severe asthma of
children and adolescents. Thirty patients admitted to Children's Orthopedic Hospital and …

A double blind cross‐over trial of the responses of asthmatic patients to 2 microaerosol
bronchodilators, isoproterenol and metaproterenol, was conducted. Drug effects were …

We tested the relative efficacy of bronchodilators delivered in aerosol and in oral form in 17
patients with asthma in a double-blind randomized sequence. Treatment consisted of a 20 …